IVDA Nasdaq Services-Prepackaged Software Financials FY2012βFY2025
Iveda Solutions, Inc. had $5.3M of revenue in fiscal 2025, down 12.3% on the year before.
Last close Β· Oct 23, 2026
$0.23
1.1%Hi! I read Iveda Solutions, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β12.3%
No. Sales fell 12.3% last year.
Does it make a profit?
β60.6%
No. It lost money last year.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Iveda Solutions, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 13, 2026
Friday Β· in 19 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 14, 2026 | Q2 '26 | After the market closes | 10-Q β |
| May 15, 2026 | Q1 '26 | After the market closes | 10-Q β |
| Mar 31, 2026 | Q4 '25 | After the market closes | 10-K β |
| Nov 14, 2025 | Q3 '25 | Before the market opens | 10-Q β |
| Aug 14, 2025 | Q2 '25 | After the market closes | 10-Q β |
| May 13, 2025 | Q1 '25 | After the market closes | 10-Q β |
| Apr 15, 2025 | Q4 '24 | After the market closes | 10-K β |
| Nov 14, 2024 | Q3 '24 | After the market closes | 10-Q β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Iveda Solutions, Inc. had $5.3M of revenue in fiscal 2025, down 12.3% on the year before. Its operating margin was β61.1%, up 6.5Β pts: of every 100 in sales, about β61 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Iveda Solutions, Inc. lost $3.2M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Iveda Solutions, Inc. has $4.6M more cash than debt.
Cash, debt and the ratios that show how comfortably Iveda Solutions, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.4M | $7.3M | $4.7M | $2.6M | $5.2M |
| Debt incl. finance leases | $0.4M | $0.6M | $0.3M | $0.8M | $0.6M |
| Debt / equity | β | 0.1x | 0.1x | 0.3x | 0.1x |
| Interest coverage | β10.0x | β62.5x | β553.5x | β155.4x | β88.4x |
| Current ratio | 0.8x | 4.5x | 3.6x | 2.2x | 4.9x |
| Quick ratio | 0.7x | 4.3x | 3.4x | 2.1x | 4.7x |
| Total assets | $3.0M | $9.9M | $6.3M | $5.2M | $6.4M |
| Total liabilities | $3.8M | $2.3M | $1.5M | $2.7M | $1.6M |
| Shareholders' equity | β$0.8M | $7.6M | $4.6M | $2.5M | $4.8M |
| Net debt (β = net cash) | β$1.0M | β$6.7M | β$4.4M | β$1.8M | β$4.6M |
KIRA Β· Its return on capital was β1,445.2%: every 100 invested in the business earned about β1,445 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Iveda Solutions, Inc. passes 5 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY12 | FY13 | FY14 | FY15 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 2 / 9 | 3 / 9 | β / 5 | 3 / 9 | 4 / 9 | 2 / 9 | 5 / 9 |
| Accruals ratio | β10.5% | β74.2% | 117.0% | β37.8% | β48.5% | 32.1% | β10.0% | 7.6% | β20.2% |
| Altman Z'' | β15.37 | β31.81 | β38.30 | β55.90 | β53.13 | β8.62 | β21.97 | β34.31 | β23.93 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY12 | FY13 | FY14 | FY15 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6M | $3.3M | $2.2M | $3.1M | β | $1.9M | $4.5M | $6.5M | $6.0M | $5.3M |
| Gross profit | $0.4M | $0.6M | $0.6M | $0.7M | β | $0.8M | $1.0M | $1.1M | $1.3M | $1.3M |
| Research and development | β | $0.3M | $0.3M | $0.3M | β | β | β | $0.8M | $0.4M | $0.2M |
| Operating income | β$3.8M | β$6.8M | β$5.0M | β$3.3M | β | β$2.7M | β$3.3M | β$4.0M | β$4.1M | β$3.2M |
| Interest expense | $0.1M | $0.1M | $0.5M | $0.4M | β | $0.3M | $0.1M | $0.0M | $0.0M | $0.0M |
| Pretax income | β$3.9M | β$6.9M | β$5.6M | β$3.8M | β | β$3.0M | β$3.3M | β$4.1M | β$3.9M | β$3.2M |
| Income tax | β$0.1M | β$0.1M | $0.0M | $0.0M | β | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$3.8M | β$6.8M | β$0.8M | β$3.8M | β | β$3.0M | β$3.3M | β$4.1M | β$4.0M | β$3.2M |
| Diluted EPS | β$0.20 | β$0.27 | β$0.03 | β$0.14 | β | β$0.04 | β$0.26 | β$2.07 | β$1.81 | β$0.88 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B | β | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$3.3M | β$3.6M | β$5.0M | β$2.7M | β | β$2.0M | β$5.4M | β$3.3M | β$4.4M | β$2.0M |
| Capital expenditure | $0.3M | $0.2M | $0.3M | $0.0M | β | $0.0M | $0.0M | $0.1M | $0.0M | β |
| Free cash flow | β$3.7M | β$3.8M | β$5.3M | β$2.7M | β | β$2.0M | β$5.4M | β$3.4M | β$4.4M | β |
| Depreciation and amortization | $0.2M | $0.2M | $0.2M | $0.2M | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Stock-based compensation | $0.2M | $0.3M | $0.4M | $0.2M | β | $0.8M | $0.1M | $0.1M | $0.1M | $0.4M |
| Dividends paid | β | β | β | $0.0M | β | β | β | β | β | β |
| Dividends and buybacks | β | β | β | $0.0M | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.1M | $0.6M | $0.1M | $0.2M | $0.2M | $1.4M | $7.3M | $4.7M | $2.6M | $5.2M |
| Total debt | $0.9M | $0.6M | $1.1M | $0.1M | $0.9M | $0.4M | $0.6M | $0.3M | $0.8M | $0.6M |
| Current assets | $3.3M | $2.6M | $2.5M | $2.0M | $1.0M | $2.7M | $9.6M | $5.9M | $5.0M | $6.2M |
| Current liabilities | $3.7M | $2.7M | $4.0M | $3.4M | $4.5M | $3.4M | $2.1M | $1.7M | $2.3M | $1.3M |
| Inventory | $0.1M | $0.3M | $0.4M | $0.2M | $0.2M | $0.3M | $0.5M | $0.3M | $0.1M | $0.2M |
| Property and equipment, net | $0.5M | $0.5M | $0.5M | $0.2M | $0.0M | $0.0M | $0.0M | $0.1M | $0.1M | $0.0M |
| Goodwill | $0.8M | $0.0M | β | β | β | β | β | β | β | β |
| Intangible assets | β | β | $0.1M | $0.1M | $0.0M | $0.0M | β | $0.8M | β | β |
| Total assets | $4.9M | $3.7M | $3.5M | $2.4M | $1.2M | $3.0M | $9.9M | $6.3M | $5.2M | $6.4M |
| Total liabilities | $3.7M | $3.2M | $4.2M | $4.1M | $5.0M | $3.8M | $2.3M | $1.5M | $2.7M | $1.6M |
| Preferred stock | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Shareholders' equity | $1.2M | $0.5M | β$0.8M | β$1.6M | β$3.7M | β$0.8M | $7.6M | $4.6M | $2.5M | $4.8M |
| Margins | ||||||||||
| Gross margin | 10.5% | 18.4% | 26.2% | 22.2% | β | 43.4% | 21.6% | 16.4% | 21.6% | 24.1% |
| Operating margin | β106.5% | β203.3% | β226.9% | β108.6% | β | β142.1% | β74.5% | β62.2% | β67.6% | β61.1% |
| EBITDA margin | β100.5% | β196.6% | β216.6% | β102.4% | β | β141.3% | β74.1% | β61.9% | β67.1% | β60.7% |
| Net margin | β106.5% | β203.3% | β38.4% | β123.2% | β | β156.4% | β74.9% | β63.8% | β66.1% | β60.6% |
| FCF margin | β101.6% | β112.7% | β242.5% | β87.6% | β | β104.1% | β121.4% | β52.6% | β73.5% | β |
| Returns | ||||||||||
| Return on capital | β151.0% | β937.2% | β1,446.9% | β | β | β | β310.6% | β1,233.5% | β473.4% | β1,445.2% |
| Return on capital employed | β308.0% | β711.1% | 1,025.8% | 341.8% | β | 621.5% | β42.9% | β86.9% | β141.3% | β62.5% |
| Return on equity | β325.4% | β799.1% | β | β | β | β | β98.5% | β67.8% | β111.3% | β87.8% |
| Return on assets | β78.1% | β158.2% | β23.4% | β127.6% | β | β141.7% | β52.1% | β51.2% | β69.3% | β55.1% |
| Return on tangible equity | β1,131.3% | β1,303.5% | β | β | β | β | β44.2% | β107.4% | β158.9% | β66.9% |
| Growth | ||||||||||
| Revenue growth | β | β7.3% | β34.7% | 40.5% | β | β | 133.0% | 45.4% | β7.3% | β12.3% |
| Share count change | β | 29.7% | 10.4% | 1.0% | β | β | 43.7% | β84.5% | 10.4% | 65.2% |
| Financial health | ||||||||||
| Debt / equity | 0.8x | 1.2x | β | β | β | β | 0.1x | 0.1x | 0.3x | 0.1x |
| Interest coverage | β48.2x | β81.3x | β10.4x | β8.4x | β | β10.0x | β62.5x | β553.5x | β155.4x | β88.4x |
| Current ratio | 0.9x | 0.9x | 0.6x | 0.6x | 0.2x | 0.8x | 4.5x | 3.6x | 2.2x | 4.9x |
| Quick ratio | 0.9x | 0.8x | 0.5x | 0.5x | 0.2x | 0.7x | 4.3x | 3.4x | 2.1x | 4.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 9.4% | 4.7% | 12.3% | 0.9% | β | 1.3% | 0.3% | 1.3% | 0.0% | β |
| Stock comp / revenue | 6.9% | 10.1% | 17.1% | 7.1% | β | 41.8% | 2.7% | 1.6% | 2.0% | 7.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 2.0 | 3.0 | β | β | 3.0 | 4.0 | 2.0 | 5.0 |
| Altman Z'' | β15.4 | β31.8 | β38.3 | β55.9 | β | β53.1 | β8.6 | β22.0 | β34.3 | β23.9 |
| Accruals ratio | β10.5% | β74.2% | 117.0% | β37.8% | β | β48.5% | 32.1% | β10.0% | 7.6% | β20.2% |
Source: SEC EDGAR XBRL filings (CIK 0001397183). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
